Literature DB >> 31640776

Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.

Pooja Ghatalia1, Jennifer Gordetsky2, Fengshen Kuo3, Essel Dulaimi4, Kathy Q Cai4, Karthik Devarajan4, Sejong Bae2, Gurudatta Naik2, Timothy A Chan3, Robert Uzzo4, A Ari Hakimi3, Guru Sonpavde2,5, Elizabeth Plimack4.   

Abstract

Following publication of the original article [1], the author reported that the current funding section "Kidney Cancer Association Young Investigator Grant provided funding for this project" should be replaced with "Kidney Cancer Association Young Investigator Grant and Bucks County Board provided funding for this project."

Entities:  

Year:  2019        PMID： 31640776      PMCID： PMC6806554          DOI： 10.1186/s40425-019-0735-5

Source DB:  PubMed          Journal:  J Immunother Cancer        ISSN： 2051-1426            Impact factor:   13.751


Correction to: J Immunother Cancer https://doi.org/10.1186/s40425-019-0621-1 Following publication of the original article [1], the author reported that the current funding section “Kidney Cancer Association Young Investigator Grant provided funding for this project” should be replaced with “Kidney Cancer Association Young Investigator Grant and Bucks County Board provided funding for this project.”
  1 in total

1.  Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.

Authors:  Pooja Ghatalia; Jennifer Gordetsky; Fengshen Kuo; Essel Dulaimi; Kathy Q Cai; Karthik Devarajan; Sejong Bae; Gurudatta Naik; Timothy A Chan; Robert Uzzo; A Ari Hakimi; Guru Sonpavde; Elizabeth Plimack
Journal:  J Immunother Cancer       Date:  2019-05-28       Impact factor: 13.751
  1 in total
  5 in total

1.  A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarker.

Authors:  Xuxue Guo; Mei Huang; Haonan Zhang; Qianhui Chen; Ying Hu; Yan Meng; Changjie Wu; Chenge Tu; Yongfeng Liu; Aimin Li; Qingyuan Li; Peirong Zhou; Side Liu
Journal:  Cancer Cell Int       Date:  2022-07-17       Impact factor: 6.429

Review 2.  Using CRISPR to enhance T cell effector function for therapeutic applications.

Authors:  Julian J Freen-van Heeren
Journal:  Cytokine X       Date:  2020-12-21

3.  Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human cancers.

Authors:  Nuzhat Sial; Jalil Ur Rehman; Saba Saeed; Mukhtiar Ahmad; Yasir Hameed; Muhammad Atif; Abdul Rehman; Rizwan Asif; Hamad Ahmed; Muhammad Safdar Hussain; Muhammad Rashid Khan; Atifa Ambreen; Ayesha Ambreen
Journal:  Biosci Rep       Date:  2022-01-28       Impact factor: 3.840

4.  Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer.

Authors:  Nuzhat Sial; Saba Saeed; Mukhtiar Ahmad; Yasir Hameed; Abdul Rehman; Mustansar Abbas; Rizwan Asif; Hamad Ahmed; Muhammad Safdar Hussain; Jalil Ur Rehman; Muhammad Atif; Muhammad Rashid Khan
Journal:  Int J Gen Med       Date:  2021-10-21

5.  Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis.

Authors:  Sicong Li; Lanxing Li; Tianyan Pan; Xiaoqun Li; Yujia Tong; Yongdong Jin
Journal:  Front Immunol       Date:  2022-09-21       Impact factor: 8.786
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.